Immatics NV (IMTX)
9.42
-0.11
(-1.15%)
USD |
NASDAQ |
Sep 01, 16:00
9.42
0.00 (0.00%)
After-Hours: 20:00
Immatics Total Long Term Debt (Quarterly) : 16.70M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 16.70M |
| March 31, 2026 | 17.38M |
| December 31, 2025 | 18.36M |
| September 30, 2025 | 19.25M |
| June 30, 2025 | 20.09M |
| March 31, 2025 | 19.86M |
| December 31, 2024 | 16.78M |
| September 30, 2024 | 17.88M |
| June 30, 2024 | 18.66M |
| March 31, 2024 | 15.81M |
| December 31, 2023 | 17.01M |
| September 30, 2023 | 17.43M |
| June 30, 2023 | 18.35M |
| March 31, 2023 | 16.26M |
| December 31, 2022 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2022 | 0.00 |
| June 30, 2022 | 17.16M |
| March 31, 2022 | 10.30M |
| December 31, 2021 | 11.20M |
| September 30, 2021 | 8.110M |
| June 30, 2021 | 8.369M |
| March 31, 2021 | 7.467M |
| December 31, 2020 | 7.570M |
| September 30, 2020 | 8.009M |
| June 30, 2020 | 8.394M |
| March 31, 2020 | 4.22M |
| December 31, 2019 | 3.630M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| MediGene AG | -- |
| InflaRx NV | 0.9526M |
| BioNTech SE | 349.05M |
| Moderna, Inc. | 1.266B |
| Intellia Therapeutics, Inc. | 50.07M |